Authors
Cláudia Carvalho, Maria Paula Serrão, Maria Augusta Vieira Coelho
Published in
Progress in neuro-psychopharmacology & biological psychiatry. Pages 112007. Nov 14, 2026. Epub Nov 14, 2026.
Abstract
SH-SY5Y neuroblastoma cells are a widely used in vitro model for studying neuronal differentiation and monoaminergic signalling. However, their ability to produce and release catecholamines under different protocols remains insufficiently characterized. In this study, we analysed the catecholamine profile in undifferentiated cells and in three other differentiation conditions: retinoic acid (RA), 12-O-tetradecanoylphorbol-13-acetate (TPA), and sequential RA/TPA treatment. Catecholamine levels were quantified by high-performance liquid chromatography with electrochemical detection, and enzymatic activities of aromatic L-amino acid decarboxylase (AADC), dopamine β-hydroxylase (DBH), and catechol-O-methyltransferase (COMT) were assessed in TPA differentiated SH-SY5Y. Basal dopamine and noradrenaline levels were very low across all conditions. Supplementation with L-DOPA significantly enhanced catecholamine production, with the strongest effect observed in TPA-differentiated cells. This protocol also increased L-DOPA uptake as well as AADC activity, while DBH and COMT activities remained unchanged. We conclude that TPA-differentiated SH-SY5Y cells supplemented with L-DOPA provide an optimized system for modelling dopaminergic and noradrenergic pathways, supporting their application in toxicology and psychopharmacology studies.
PMID:
43033892
Bibliographic data and abstract were imported from PubMed on 15 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 8
- Comments 0